Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8
Original Research
Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,369 | Dovepress* | 8,075+ | 1,503 | 9,578 | |
| PubMed Central* | 1,294 | 444 | 1,738 | ||
| Totals | 9,369 | 1,947 | 11,316 | ||
| *Since 19 September 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed and Google Scholar